In this interview with Andrew Kleuss on Investors Hub, Vitaliy makes the case that concerns over Amazon’s entry into the pharmaceuticals business are probably overblown. To parse this problem, Vitaliy differentiates between pharmacies and drug distributors, and analyzes the extent to which Amazon can compete with both. While Amazon might place some pressure on pharmacies over time, he explains how drug distributors’ unique supply chains should remain robust against a competitive threat from Amazon.
New to investing?
Explore these valuable guides to get started.
Related Articles
The Values of Value Investing – Ep 307
What are the real values of value investing? It’s not just cheap stocks—it’s quality, growth, and the wisdom to know the difference.
The World’s Best-Prepared Patient – Ep 306
Nobody in this equation is flawless: not doctors, not us, and not even AI. It hallucinates, making up stories like a Hollywood screenwriter. But it also has perfect recall and lacks the myopic vision of human beings. … That’s the model. Not AI instead of your doctor.
The AI Hangover Is Coming. The Pandemic Already Showed Us How It Ends. – Ep 305
We don’t have to go decades back to find an analogy. Just look back a few years, to the pandemic. We all lived through it, most of us in sweatpants. And it offers a near-perfect preview of what is about to happen in AI.
Your Sophist Filter: On CEOs, Cynics, and the Voice in Your Head – Ep 304
A great speaker can bend logic with emotions and exert undue influence on your decision making. The better someone speaks, the more discriminating your Sophist filter needs to be.
comments
0